Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission
Open accessThe DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index; 40 of the 148 sources its claims cite were checked for support.
Abstract
Aims/hypothesis: Weight reduction is fundamental for type 2 diabetes management and remission, but uncertainty exists over which diet type is best to achieve and maintain weight loss. We evaluated dietary approaches for weight loss, and remission, in people with type 2 diabetes to inform practice and clinical guidelines. Methods: First, we conducted a systematic review of published meta-analyses of RCTs of weight-loss diets. We searched MEDLINE (Ovid), PubMed, Web of Science and Cochrane Database of Systematic Reviews, up to 7 May 2021. We synthesised weight loss findings stratified by diet types and assessed meta-analyses quality with A Measurement Tool to Assess Systematic Reviews (AMSTAR) 2. We assessed certainty of pooled results of each meta-analysis using Grading of Recommendations, Assessment, Development and Evaluations (GRADE) (PROSPERO CRD42020169258). Second, we conducted a systematic review of any intervention studies reporting type 2 diabetes remission with weight-loss diets, in MEDLINE (via PubMed), Embase and Cochrane Central Register of Controlled Trials, up to 10 May 2021. Findings were synthesised by diet type and study quality (Cochrane Risk of Bias tool 2.0 and Risk Of Bias In Non-randomised Studies – of Interventions [ROBINS-I]), with GRADE applied (PROSPERO CRD42020208878). Results: We identified 19 meta-analyses of weight-loss diets, involving 2–23 primary trials ( n = 100–1587), published 2013–2021. Twelve were ‘critically low’ or ‘low’ AMSTAR 2 quality, with seven ‘high’ quality. Greatest weight loss was reported with very low energy diets, 1.7–2.1 MJ/day (400–500 kcal) for 8–12 weeks (high-quality meta-analysis, GRADE low), achieving 6.6 kg (95% CI −9.5, −3.7) greater weight loss than low-energy diets (4.2–6.3 MJ/day [1000–1500 kcal]). Formula meal replacements (high quality, GRADE moderate) achieved 2.4 kg (95% CI −3.3, −1.4) greater weight loss over 12–52 weeks. Low-carbohydrate diets were no better for weight loss than higher-carbohydrate/low-fat diets (high quality, GRADE high). High-protein, Mediterranean, high-monounsaturated-fatty-acid, vegetarian and low-glycaemic-index diets all achieved minimal (0.3–2 kg) or no difference from control diets (low to critically low quality, GRADE very low/moderate). For type 2 diabetes remission, of 373 records, 16 met inclusion criteria. Remissions at 1 year were reported for a median 54% of participants in RCTs including initial low-energy total diet replacement (low-risk-of-bias study, GRADE high), and 11% and 15% for meal replacements and Mediterranean diets, respectively (some concerns for risk of bias in studies, GRADE moderate/low). For ketogenic/very low-carbohydrate and very low-energy food-based diets, the evidence for remission (20% and 22%, respectively) has serious and critical risk of bias, and GRADE certainty is very low. Conclusions/interpretation: Published meta-analyses of hypocaloric diets for weight management in people with type 2 diabetes do not support any particular macronutrient profile or style over others. Very low energy diets and formula meal replacement appear the most effective approaches, generally providing less energy than self-administered food-based diets. Programmes including a hypocaloric formula ‘total diet replacement’ induction phase were most effective for type 2 diabetes remission. Most of the evidence is restricted to 1 year or less. Well-conducted research is needed to assess longer-term impacts on weight, glycaemic control, clinical outcomes and diabetes complications. Graphical abstract:
Overview
CoChat Summary
TL;DR
This umbrella review of meta-analyses and systematic review of remission trials found no clear superiority of any macronutrient profile or diet style for weight loss in adults with type 2 diabetes. Very low energy diets and formula meal replacement produced greater weight loss, and total diet replacement programmes were most effective for type 2 diabetes remission, but most evidence was limited to ≤1 year.
Key findings
- In 19 meta-analyses (2–23 primary trials; n = 100–1587), very low energy diets (1.7–2.1 MJ/day [400–500 kcal] for 8–12 weeks) achieved 6.6 kg greater weight loss than low-energy diets (95% CI −9.5, −3.7; high-quality meta-analysis, GRADE low). Formula meal replacements achieved 2.4 kg greater weight loss over 12–52 weeks (95% CI −3.3, −1.4; high quality, GRADE moderate).
- Low-carbohydrate diets were no better for weight loss than higher-carbohydrate/low-fat diets (high quality, GRADE high). High-protein, Mediterranean, high-monounsaturated-fatty-acid, vegetarian and low-glycaemic-index diets all achieved minimal (0.3–2 kg) or no difference from control diets (low to critically low quality, GRADE very low/moderate).
- For remission, 16 studies met inclusion criteria. At 1 year, median 54% remission (range 46–61%) was reported in RCTs including initial low-energy total diet replacement versus 4–12% in usual care (N = 445, 2 RCTs; GRADE high). Meal replacement achieved 11% versus 2% (N = 4503; GRADE moderate/low), and Mediterranean diet achieved 15% versus 4% (N = 215; GRADE low). Ketogenic/very low-carbohydrate and very low-energy food-based diets reported 20% and 22% remission, respectively, with serious/critical risk of bias and GRADE very low certainty.
- Single-arm/non-randomised studies reported higher remission than RCTs; shorter type 2 diabetes duration and Asian ethnicity were associated with greater likelihood of remission. Adherence up to 1 year was poorer with very low-carbohydrate diets (<50 g carbohydrate) than with low-carbohydrate diets (<130 g carbohydrate).
Methods
- Umbrella review of published meta-analyses of RCTs of weight-loss diets in type 2 diabetes; searched MEDLINE (Ovid), PubMed, Web of Science and Cochrane Database of Systematic Reviews to 7 May 2021; quality assessed with AMSTAR 2 and certainty with GRADE (PROSPERO CRD42020169258).
- Systematic review of any intervention studies reporting type 2 diabetes remission with weight-loss diets; searched MEDLINE (via PubMed), Embase and Cochrane Central Register of Controlled Trials to 10 May 2021; included RCTs and non-randomised studies, assessed with Cochrane Risk of Bias 2.0 and ROBINS-I, and GRADE (PROSPERO CRD42020208878). Findings were synthesised by diet type without meta-analysis due to limited and heterogeneous studies; intention-to-treat remission was computed when only completer data were reported.
Limitations
- The paper states that many included meta-analyses were of low or critically low AMSTAR 2 quality, predominantly because no protocol was reported and publication bias was not assessed; many had fewer than ten RCTs, limiting funnel-plot assessment. AMSTAR 2 criteria can be subjective, and if relaxed for protocol reporting and publication bias, the meta-analyses allow some confidence in the consistent findings of little/no difference between diets.
- The paper states that most included studies were in European participants, so results may not apply equally to other ethnic and/or deprived communities; South Asians may be more sensitive to weight loss. It also notes insufficient detail on macronutrient/micronutrient contents and prescribed/reported energy intakes, varied control diets, varied intervention durations, and that most evidence relates to ≤1 year.
- Evident from the text: remission evidence is limited, with only two RCTs having remission as the pre-specified outcome; many non-randomised studies had critical risk of bias, lacked comparator groups and/or randomisation, and may retain residual confounding. Some studies did not routinely withdraw glucose-lowering medications, so only minimum remissions can be reported, and no RCT evaluated low-carbohydrate/ketogenic diets for remission.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 All published meta-analyses of intervention diets vs control diets on weight loss (kg) stratified by overall quality in each diet type using AMSTAR 2 quality (green, high quality; orange, low quality; red, critically low quality). WMDs are presented alongside 95% CIs (error bars). Pooled results of McArdle et al., 2019 [34], Fan et al., 2016 [27], Zafar et al., 2019 [36] and Zhao et al., 2018 [30] are standardised mean differences. aComplete case data. GRADE level for certainty of evidence is rated as follows: ‘high’ indicates that we are very confident that the true effect lies close to that of the estimate of the effect; ‘moderate’ indicates that we are moderately confident in the effect estimate (the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different); ‘low’ indicates that our confidence in the effect estimate is limited (the true effect may be substantially different from the estimate of the effect); and ‘very low’ indicates that we have very little confidence in the effect estimate (the true effect is likely to be substantially different from the estimate of effect)](https://figures.cochat.ai/paper-figures/2d1d6a78db1745e88f536ce4e1adeb3f/diets-for-weight-management-in-adults-with-type-2-diabetes-an-umbrella-review-of-figure-2.jpg)


Verification
Claims the paper makes
17 Valid · 3 Not valid · 61 Not checked · 85 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Five studies compared diet interventions with usual care according to clinical guidelines, without providing foods or dietary products for participants [49–53].”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (2) Systematic review of intervention studies (either RCTs or NRSs) of diets for remission of type 2 diabetes
What the sources say
- Could not verifycites [49] Gregg EW, Chen H, Wagenknecht LE et al (2012) Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308(23):2489–2496. https://doi.org/10.1001/jama.2012.67929 sourceExperimental — accuracy not yet measured
Our copy of Gregg et al. (2012) is the Look AHEAD trial report on diabetes remission; no passage enumerates or characterizes five diet-vs-usual-care trials, nor discusses whether foods or dietary products were supplied to participants. Searches for 'diet intervention compared with usual care without providing foods', 'meal replacements provided participants', 'five studies', and 'prior randomized trials diet clinical guidelines' returned only the study's own Intervention section (which states the opposite for Look AHEAD: 'Liquid meal replacements were provided to assist dietary goals') and reference-list entries such as Andrews et al.'s Early ACTID trial (ref 32). The Comment (references pp., section 'References') cites individual diet/usual-care and prevention trials but never aggregates them as five such studies, so the claim's point is not addressed in our copy. (LLM, conf=0.70)
- Supportedcites [50] Hallberg SJ, McKenzie AL, Williams PT et al (2018) Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: an open-label, non-randomized, controlled study. Diabetes Ther 9(2):583–612. https://doi.org/10.1007/s13300-018-0373-9 source
Hallberg et al. (2018) is exactly the kind of study the citing sentence enumerates: Methods (Continuous Care Intervention) describe individualized nutrition recommendations targeting nutritional ketosis, compared against a Usual Care cohort (Methods, Usual Care) whose care was unmodified by the study and followed local diabetes education/standard medical care cited to the ADA Standards of Medical Care in Diabetes (ref [7]). The Discussion (Study Strengths and Weaknesses) explicitly lists 'lack of food provision' as a feature of the trial, so no foods or dietary products were supplied; supplements (multivitamin, vitamin D3, omega-3, magnesium) appear only as advice, not provision. The count of five studies is the citing paper's synthesis across refs 49-53, of which this source is one verified example. (LLM, conf=0.86)
- Disputedcites [51] Lean ME, Leslie WS, Barnes AC et al (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391(10120):541–551. https://doi.org/10.1016/S0140-6736(17)33102-1 sourceExperimental — accuracy not yet measured
DiRECT does match the 'diet intervention vs usual care under clinical guidelines' half of the claim: Randomisation and masking states practices were assigned to the Counterweight-Plus programme 'or best-practice care by guidelines (control)', and Procedures notes both groups continued diabetes care under NICE and SIGN guidelines. But it contradicts the qualifier 'without providing foods or dietary products': Procedures (Participants in the intervention group...) describes a total diet replacement phase using a low energy formula diet (825-853 kcal/day) for 3 months, and Acknowledgements state 'The formula diet was donated by Cambridge Weight Plan', i.e. a proprietary dietary product was supplied to intervention participants (along with step counters at food reintroduction). So this trial belongs to the opposite category from the one the citing sentence assigns it. (LLM, conf=0.80)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [52] Mollentze WF, Joubert G, Prins A, van der Linde S, Marx GM, Tsie KG (2019) The safety and efficacy of a low-energy diet to induce weight loss, improve metabolic health, and induce diabetes remission in insulin-treated obese men with type 2 diabetes: a pilot RCT. Int J Diabetes Dev C 39(4):618–625. https://doi.org/10.1007/s13410-019-00734-1 sourceExperimental — accuracy not yet measured
Our copy confirms only that this is an RCT comparing a diet intervention with a non-diet-product control arm: the Study design section describes a 6-month comparison of 'a commercial weight loss program with a standard nutrition intervention', and the Control group section (p. n/a) says a dietitian gave each control subject 'a balanced personalized energy-restricted meal plan'. Two elements of the claim are not supported: the comparator is not described as 'usual care according to clinical guidelines' — control subjects also received the same 2-h interactive training programme as the intervention arm and weekly facility visits for insulin adjustment, and no passage ties the control plan to SEMDSA or any guideline (reference 22 to the SEMDSA medical nutrition therapy guideline appears only in the reference list). The 'without providing foods or dietary products' qualifier is also not established: the intervention arm's plan was built around a commercial dietary product (CSN vegetable soup reconstituted from desiccated vegetable powder), and our copy nowhere states that no foods or products were supplied. (LLM, conf=0.65)
- Not checked yetcites [53] Taheri S, Zaghloul H, Chagoury O et al (2020) Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 8(6):477–489. https://doi.org/10.1016/S2213-8587(20)30117-0 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In the Doctor Referral of Overweight People to Low Energy total diet replacement Treatment (DROPLET) trial among people without diabetes, in routine practice, a total diet replacement programme (formula diets) with behavioural support proved more cost-effective than nurse-led dietary advice for long-term prevention of obesity-related diseases [62].”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Discussion > Dietary weight reduction for people with type 2 diabetes
What the sources say
- Disputedcites [62] Kent S, Aveyard P, Astbury N, Mihaylova B, Jebb SA (2019) Is doctor referral to a low-energy total diet replacement program cost-effective for the routine treatment of obesity? Obesity (Silver Spring) 27(3):391–398. https://doi.org/10.1002/oby.22407 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 1 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“We first included RCTs reporting type 2 diabetes remission as the primary outcome, the design most likely to provide trustworthy evidence. However, as few such RCTs have been conducted, we also evaluated non-randomised studies (NRSs) to capture the totality of the evidence for ‘best available advice’ to inform practice and policy [20].”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Methods > (2) Systematic review of diets for type 2 diabetes remission
What the sources say
- Could not verifycites [20] Schunemann HJ, Tugwell P, Reeves BC et al (2013) Non-randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions. Res Synth Methods 4(1):49–62. https://doi.org/10.1002/jrsm.1078 sourceExperimental — accuracy not yet measured
The source discusses when non-randomized studies can complement limited RCT evidence (section 3.1, p. 8), but it does not say how many RCTs have examined type 2 diabetes remission as a primary outcome. Searches for that outcome and for diabetes-remission trials found no passage addressing the claim. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Most meta-analyses were of critically low (n = 7; [25–31]) to low quality (n = 5; [32–36]).”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (1) Umbrella review of published meta-analyses of RCTs of diets for weight loss and glycaemic control
What the sources say
- Not checked yetcites [25] Pan B, Wu Y, Yang Q et al (2019) The impact of major dietary patterns on glycemic control, cardiovascular risk factors, and weight loss in patients with type 2 diabetes: a network meta-analysis. J Evid Based Med 12(1):29–39. https://doi.org/10.1111/jebm.12312 source
- Supportedcites [26] Ajala O, English P, Pinkney J (2013) Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 97(3):505–516. https://doi.org/10.3945/ajcn.112.042457 source
The Statistical analysis section states that the paper undertook meta-analyses of dietary-intervention subgroups. The citation identifies this paper as one of the meta-analyses assessed; the critically low quality rating is the citing authors’ assessment, not a finding attributed to this paper. (LLM, conf=0.87)
- Not checked yetcites [27] Fan YF, Di HJ, Chen GF, Mao XD, Liu C (2016) Effects of low carbohydrate diets in individuals with type 2 diabetes: systematic review and meta-analysis. Int J Clin Exp Med 9(6):11166–11174
- Could not verifycites [28] Pfeiffer AFH, Pedersen E, Schwab U et al (2020) The effects of different quantities and qualities of protein intake in people with diabetes mellitus. Nutrients 12(2):365. https://doi.org/10.3390/nu12020365 sourceExperimental — accuracy not yet measured
The Methods section describes GRADE evidence categories, and §2.2 says available meta-analyses did not meet the authors’ inclusion criteria. Neither passage rates seven meta-analyses as critically low quality or five as low quality; searches for those counts and for a critically low quality assessment found no such passage in our copy. (LLM, conf=0.74)
- Not checked yetcites [29] Qian F, Korat AA, Malik V, Hu FB (2016) Metabolic effects of monounsaturated fatty acid-enriched diets compared with carbohydrate or polyunsaturated fatty acid-enriched diets in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care 39(8):1448–1457. https://doi.org/10.2337/dc16-0513 source
- Supportedcites [30] Zhao WT, Luo Y, Zhang Y, Zhou Y, Zhao TT (2018) High protein diet is of benefit for patients with type 2 diabetes: an updated meta-analysis. Medicine 97(46):e13149. https://doi.org/10.1097/MD.0000000000013149 source
The citation identifies one of the meta-analyses assessed by the citing authors. The Results, under “Characteristics of included studies,” state that this paper included 18 studies in its meta-analysis. The critically-low rating and the counts are the citing authors’ assessment, not findings attributed to this source. (LLM, conf=0.85)
- Supportedcites [31] Snorgaard O, Poulsen GM, Andersen HK, Astrup A (2017) Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. BMJ Open Diabetes Res Care 5(1):e000354. https://doi.org/10.1136/bmjdrc-2016-000354 source
The citation identifies one of the meta-analyses assessed by the citing authors, rather than attributing the quality counts to this paper. The source is itself a systematic review and meta-analysis, as its title states; its Results section discusses its evaluation of other reviews. The critically low and low ratings are the citing authors’ assessments, not findings this source needs to report. (LLM, conf=0.84)
- Not checked yetcites [32] Huo R, Du T, Xu Y et al (2015) Effects of Mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: a meta-analysis. Eur J Clin Nutr 69(11):1200–1208. https://doi.org/10.1038/ejcn.2014.243 source
- Not checked yetcites [33] Meng Y, Bai H, Wang S, Li Z, Wang Q, Chen L (2017) Efficacy of low carbohydrate diet for type 2 diabetes mellitus management: a systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract 131:124–131. https://doi.org/10.1016/j.diabres.2017.07.006 source
- Partly supportedcites [34] McArdle PD, Greenfield SM, Rilstone SK, Narendran P, Haque MS, Gill PS (2019) Carbohydrate restriction for glycaemic control in type 2 diabetes: a systematic review and meta-analysis. Diabet Med 36(3):335–348. https://doi.org/10.1111/dme.13862 sourceExperimental — accuracy not yet measured
The Data Sources and Searches section (p. 5) identifies this work as a systematic review and meta-analysis, so it can serve as an example of a meta-analysis. The Data Extraction and Quality Assessment section (p. 5) assesses bias in included studies, not the quality of meta-analyses; our copy does not substantiate the critically low or low ratings or the counts of seven and five. (LLM, conf=0.80)
plainn = 7- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A non-diabetic state can be restored for 2 years for 70–80% of people with type 2 diabetes by interventions that maintain over 10 kg weight loss (36/149, 24% of participants in the Diabetes Remission Clinical Trial [DiRECT]) [7], which sustains loss of ectopic fat, reversing the pathophysiology and normalising pancreas morphology [8].”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Introduction
What the sources say
- Partly supportedcites [7] Thom G, Messow CM, Leslie WS et al (2021) Predictors of type 2 diabetes remission in the diabetes remission clinical trial (DiRECT). Diabet Med 38(8):e14395. https://doi.org/10.1111/dme.14395 sourceExperimental — accuracy not yet measured
Figure 2 reports remission at two years in 78.9% of participants who lost 10–<15 kg and 82.4% of those who lost ≥15 kg; its counts show that 36/149 participants maintained a loss of at least 10 kg. The claim broadly says “people with type 2 diabetes,” but the Discussion says DiRECT studied people with relatively short-duration diabetes, predominantly white Europeans, and that evidence is needed for people with longer disease duration and other ethnicities. (LLM, conf=0.88)
- Partly supportedcites [8] Al-Mrabeh A, Hollingsworth KG, Shaw JAM et al (2020) 2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol 8(12):939–948. https://doi.org/10.1016/S2213-8587(20)30303-X sourceExperimental — accuracy not yet measured
The Introduction reports that DiRECT achieved non-diabetic blood glucose control for two years, but gives 36% of the intervention group, not 70–80%. The Clinical and metabolic studies section describes weight maintenance through 24 months, but our copy does not establish the claimed 70–80% remission rate among people maintaining more than 10 kg of weight loss. In the citing sentence, this paper is cited for the subsequent pancreas-morphology claim, which its Discussion supports. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
91 more claims · 8 with their cited sources checked
Create a free account to see all 166 claims and to verify the 108 references still open.
- Probably not a substantial claim. 32
- It may state two separate claims as one. 46
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While bariatric surgery has established that long-term type 2 diabetes remission is possible for many, with reduced clinical events, 36,37”
From 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study (2024) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“VLCDs are very effective at achieving weight loss and significant improvement in cardiometabolic parameters in short periods [221,222], including diabetes remission”
From Lifestyle Medicine for Obesity in the Era of Highly Effective Anti-Obesity Treatment (2025) · cites this paper as [223]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As a result, the evidence does not identify one eating plan or a certain macronutrient composition that is clearly superior to other [177] and can be generally recommended for weight loss for people with T2DM [178].”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [177]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (2) Systematic review of intervention studies (either RCTs or NRSs) of diets for remission of type 2 diabetes
“compared with 2% (43/2170) in standard care (N = 4503; GRADE low certainty of evidence)”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (2) Systematic review of intervention studies (either RCTs or NRSs) of diets for remission of type 2 diabetes
“| Meal replacement | Meal replacement likely leads to T2D remission by 11% from baseline, when compared with standard care plus diabetes education (2%). | 4503 (1 RCT) | ⊕⊕◯MODERATEDue to possible publication bias |”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (1) Umbrella review of published meta-analyses of RCTs of diets for weight loss and glycaemic control
“One high-quality meta-analysis [43] of two RCTs reported that VLEDs”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (1) Umbrella review of published meta-analyses of RCTs of diets for weight loss and glycaemic control
“| Rehackova et al., 2016 [43] | Low |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (1) Umbrella review of published meta-analyses of RCTs of diets for weight loss and glycaemic control
“Most meta-analyses were of critically low (n = 7; [25–31]) to low quality (n = 5; [32–36]).”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (1) Umbrella review of published meta-analyses of RCTs of diets for weight loss and glycaemic control
“| Zafar et al., 2019 [36] | Critically low |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“For completer analysis, remission rate was 4.6% calculated from 52 out of 88 completers”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (2) Systematic review of intervention studies (either RCTs or NRSs) of diets for remission of type 2 diabetes
Reported 4.6 · recomputed 59.090909
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (2) Systematic review of intervention studies (either RCTs or NRSs) of diets for remission of type 2 diabetes
“1 yr: 71.1% (32/45)5 yr: 42.2%h (19/45)”
§ Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission > Results > (2) Systematic review of intervention studies (either RCTs or NRSs) of diets for remission of type 2 diabetes
“For completer analysis, remission rate was 46.3% calculated from available data at 12 months (19 out of 41 completers)”
2 more findings
Create a free account to see every finding of this check.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787 · cited 2×
“0 [21] and Risk Of Bias In Non-randomised Studies – of Interventions (ROBINS-I) [22] were used for quality assessment of RCTs and NRSs, respectively.”
BackgroundMethodROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J., Bossuyt, P., Boutron, I., Hoffmann, T., mulrow, C., Shamseer, L., Tetzlaff, J., Akl, E., Brennan, S. E., et al. (2020) · doi:10.31222/osf.io/v7gm2_v1 · Cited by 8,090
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J., Bossuyt, P., Boutron, I., Hoffmann, T., mulrow, C., Shamseer, L., Tetzlaff, J., Akl, E., Brennan, S. E., et al. (2020) · doi:10.31222/osf.io/v7gm2 · Cited by 5,177
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline
Campbell, M., McKenzie, J. E., Sowden, A., Katikireddi, S. V., Brennan, S. E., Ellis, S., Hartmann-Boyce, J., Ryan, R., Shepperd, S., Thomas, J., et al. (2020) · BMJ · doi:10.1136/bmj.l6890 · Cited by 4,628 · cited 1×
“Our paper is written in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 [18] and the Synthesis Without Metaanalysis in systematic reviews: reporting guideline [19].”
MethodFerence, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx144 · Cited by 3,962
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095 · cited 3×
“Most type 2 diabetes is treated in primary care, the setting for both published remission trials using an intensive ‘total diet replacement’ induction phase with formula diets [51].”
BackgroundResultSelf-citationPathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743 · cited 1×
“Its onset is primarily driven by weight gain to an excessive level for that individual, in a complex disease process involving gut hormones, low-grade inflammation and metabolites, possibly including some from the gut microbiota [1].”
BackgroundNutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496 · cited 1×
“Although all diet types are similarly effective for weight control, health risks were not systematically reported across the studies, and could differ [72].”
BackgroundLim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164 · cited 1×
“During an intensive weight loss programme, or early after bariatric surgery, there are already significant improvements in hepatic and muscle insulin sensitivity, and pancreatic first-phase insulin secretion, with rapid loss of ectopic fat from skeletal muscle and liver [2, 3, 6].”
BackgroundLean, M. E. J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30068-3 · Cited by 1,017 · cited 1×
“Only two RCTs had remission as the prespecified outcome, both relatively large and using almost identical designs and diets, with very similar results, but in very different populations, notably with different durations of diabetes [51, 53, 89].”
ResultSelf-citationHow do we define cure of diabetes?
Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., et al. (2009) · Diabetes Care · doi:10.2337/dc09-9036 · Cited by 1,003
Maintenance of Lost Weight and Long-Term Management of Obesity
Hall, K. D., & Kahan, S. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.08.012 · Cited by 876 · cited 1×
“Nutrient-specific effects have been postulated, but are likely to be overwhelmed by variable behavioural responses to dietary advice [65].”
BackgroundDiets with high or low protein content and glycemic index for weight-loss maintenance
Larsen, T. M., Dalskov, S.-M., van Baak, M., Jebb, S. A., Papadaki, A., Pfeiffer, A. F. H., Martinez, J. A., Handjieva-Darlenska, T., Kunešová, M., Pihlsgård, M., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007137 · Cited by 843 · cited 1×
“One large RCT of high-protein diet suggested benefit for weight loss maintenance, increasing satiety and energy expenditure, albeit for a maintenance phase of only 6 months after completing weight loss [64].”
BackgroundAjala, O., English, P., & Pinkney, J. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.042457 · Cited by 821 · cited 7×
“…weeks to 2 years 6 months to 1 year 2−52 weeks 4−15 months 4 weeks to 2 years 1 year High-protein diet Qian et al, 2016 [29] High-MUFA diet Huo et al, 2015 [32] Ajala et al, 2013 [26] Mediterranean diet Zafar et al, 2019 [36] Ajala et al, 2013 [26] Low-glycaemic-index diet Viguiliouk et al,…”
InfluentialAssociation of an intensive lifestyle intervention with remission of type 2 diabetes
Gregg, E. W., Chen, H., Wagenknecht, L. E., Clark, J. M., Delahanty, L. M., Bantle, J., Pownall, H. J., Johnson, K. C., Safford, M. M., Kitabchi, A. E., et al. (2012) · JAMA · doi:10.1001/jama.2012.67929 · Cited by 752
Rating the certainty in evidence in the absence of a single estimate of effect
Murad, M. H., Mustafa, R. A., Schünemann, H. J., Sultan, S., & Santesso, N. (2017) · Evidence Based Medicine · doi:10.1136/ebmed-2017-110668 · Cited by 717 · cited 1×
“GRADE assesses the certainty of synthesised findings [24].”
BackgroundHoffmann, T. C., & Del Mar, C. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.6016 · Cited by 707
Ismail, K., Winkley, K., & Rabe-Hesketh, S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16202-8 · Cited by 531
Taylor, R., Al-Mrabeh, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Aribisala, B. S., Hollingsworth, K. G., Mathers, J. C., Sattar, N., & Lean, M. E. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.003 · Cited by 450
Self-citationGoldenberg, J. Z., Day, A., Brinkworth, G. D., Sato, J., Yamada, S., Jönsson, T., Beardsley, J., Johnson, J. A., Thabane, L., & Johnston, B. C. (2021) · BMJ · doi:10.1136/bmj.m4743 · Cited by 428 · cited 3×
“4−15 months 4 weeks to 2 years 1 year High-protein diet Qian et al, 2016 [29] High-MUFA diet Huo et al, 2015 [32] Ajala et al, 2013 [26] Mediterranean diet Zafar et al, 2019 [36] Ajala et al, 2013 [26] Low-glycaemic-index diet Viguiliouk et al, 2019 [35] Vegetarian diet Goldenberg et al, 2021 [41]”
BackgroundMethodSynthesizing and presenting findings using other methods
McKenzie, J. E., & Brennan, S. E. (2019) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9781119536604.ch12 · Cited by 423 · cited 1×
“, median and interquartile ranges), without performing meta-analysis, due to the limited number and heterogeneity of studies [23].”
MethodSteven, S., Hollingsworth, K. G., Al-Mrabeh, A., Avery, L., Aribisala, B., Caslake, M., & Taylor, R. (2016) · Diabetes Care · doi:10.2337/dc15-1942 · Cited by 418
Diabetes UK evidence‐based nutrition guidelines for the prevention and management of diabetes
Dyson, P. A., Twenefour, D., Breen, C., Duncan, A., Elvin, E., Goff, L., Hill, A., Kalsi, P., Marsland, N., McArdle, P., et al. (2018) · Diabetic Medicine · doi:10.1111/dme.13603 · Cited by 410 · cited 1×
“Current guidelines state that various dietary strategies may be effective, and stress personalising weight management, to take account of social situations, but do not provide guidance over diet compositions [9, 10].”
BackgroundHallberg, S. J., McKenzie, A. L., Williams, P. T., Bhanpuri, N. H., Peters, A. L., Campbell, W. W., Hazbun, T. L., Volk, B. M., McCarter, J. P., Phinney, S. D., et al. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0373-9 · Cited by 406 · cited 2×
“Among these, three provided diabetes education or advice (Table 2) [49, 50, 52].”
BackgroundAssessing risk of bias due to missing results in a synthesis
Page, M. J., Higgins, J. P., & Sterne, J. A. (2019) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9781119536604.ch13 · Cited by 402
Hoffmann, T. C., & Del Mar, C. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.8254 · Cited by 401 · cited 1×
“For either medication or diet, weighing benefits against risks is vital: treatment benefits are often overestimated but harms underestimated [71].”
BackgroundTaheri, S., Zaghloul, H., Chagoury, O., Elhadad, S., Ahmed, S. H., El Khatib, N., Amona, R. A., El Nahas, K., Suleiman, N., Alnaama, A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30117-0 · Cited by 393 · cited 2×
“Only two RCTs had remission as the prespecified outcome, both relatively large and using almost identical designs and diets, with very similar results, but in very different populations, notably with different durations of diabetes [51, 53, 89].”
BackgroundResultfor the ADVANCE Collaborative Group, Zoungas, S., Chalmers, J., Ninomiya, T., Li, Q., Cooper, M. E., Colagiuri, S., Fulcher, G., de Galan, B. E., Harrap, S., et al. (2012) · Diabetologia · doi:10.1007/s00125-011-2404-1 · Cited by 358 · cited 1×
“5%) was defined by WHO as broadly the level where diabetes-specific microvascular complications start to emerge [90, 91].”
BackgroundSnorgaard, O., Poulsen, G. M., Andersen, H. K., & Astrup, A. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000354 · Cited by 351 · cited 5×
“…[37] van Zuuren et al, 2018 [38] Sainsbury et al, 2018 [39] Naude et al, 2014 [40] McArdle et al, 2019 (1) [34] McArdle et al, 2019 (2) [34] Meng et al, 2017 [33] Snorgaard et al, 2017 [31] Fan et al, 2016 [27] Ajala et al, 2013 [26] LCD Noronha et al, 2019 [42] Formula meal…”
BackgroundInfluentialThe Effects of High-Protein Diets on Kidney Health and Longevity
Ko, G.-J., Rhee, C. M., Kalantar-Zadeh, K., & Joshi, S. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020010028 · Cited by 345 · cited 1×
“High protein intake has been associated with kidney diseases in several observational studies [81].”
BackgroundPawlak, R., Lester, S. E., & Babatunde, T. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.46 · Cited by 343 · cited 1×
“Unless carefully designed, some diets may achieve negative energy imbalance but lack essential micronutrients [12, 13] or introduce adverse health effects through other pathways [14–16].”
BackgroundAthinarayanan, S. J., Adams, R. N., Hallberg, S. J., McKenzie, A. L., Bhanpuri, N. H., Campbell, W. W., Volek, J. S., Phinney, S. D., & McCarter, J. P. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00348 · Cited by 324
Carter, S., Clifton, P. M., & Keogh, J. B. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0756 · Cited by 299 · cited 1×
“of-bias RCTs) [46, 47], and one for time-restricted dieting reported 1.”
BackgroundAmerican Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s005 · Cited by 299
Huo, R., Du, T., Xu, Y., Xu, W., Chen, X., Sun, K., & Yu, X. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.243 · Cited by 296 · cited 2×
“Mediterranean diets Twometa-analyses, of low and critically low quality, considered weight loss from Mediterranean diets [26, 32].”
BackgroundSainsbury, E., Kizirian, N. V., Partridge, S. R., Gill, T., Colagiuri, S., & Gibson, A. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.026 · Cited by 268 · cited 4×
“Korsmo-Haugen et al, 2019 [37] van Zuuren et al, 2018 [38] Sainsbury et al, 2018 [39] Naude et al, 2014 [40] Snorgaard et al, 2017 [31] Ajala et al, 2013 [26] High-protein diet 0.30 (−1.0, 1.6) 0.10 (−0.3, 0.6) −0.14 (−1.6, 1.4) 0.58 (−0.8, 2.0) 0.91 (−2.1, 3.9) 0.20 (−1.0, 1.4) 0.4 (−1.0,…”
InfluentialNaude, C. E., Schoonees, A., Senekal, M., Young, T., Garner, P., & Volmink, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100652 · Cited by 252 · cited 5×
“carbohydrate diets (<50 g of carbohydrate) than with LCDs (<130 g of carbohydrate) [34, 37, 40], possibly because most of the trials allowed increased carbohydrate intake for later weight loss maintenance.”
BackgroundInfluentialSchünemann, H. J., Tugwell, P., Reeves, B. C., Akl, E. A., Santesso, N., Spencer, F. A., Shea, B., Wells, G., & Helfand, M. (2013) · Research Synthesis Methods · doi:10.1002/jrsm.1078 · Cited by 248 · cited 2×
“However, as few such RCTs have been conducted, we also evaluated non-randomised studies (NRSs) to capture the totality of the evidence for ‘best available advice’ to inform practice and policy [20].”
BackgroundMethodLow-glycemic index diets as an intervention for diabetes: a systematic review and meta-analysis
Zafar, M. I., Mills, K. E., Zheng, J., Regmi, A., Hu, S. Q., Gou, L., & Chen, L.-L. (2019) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz149 · Cited by 245 · cited 4×
“4−15 months 4 weeks to 2 years 1 year High-protein diet Qian et al, 2016 [29] High-MUFA diet Huo et al, 2015 [32] Ajala et al, 2013 [26] Mediterranean diet Zafar et al, 2019 [36] Ajala et al, 2013 [26] Low-glycaemic-index diet Viguiliouk et al, 2019 [35] Vegetarian diet Goldenberg et al, 2021 [41]”
BackgroundResultInfluentialKahleova, H., Belinova, L., Malinska, H., Oliyarnyk, O., Trnovska, J., Skop, V., Kazdova, L., Dezortova, M., Hajek, M., Tura, A., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3253-5 · Cited by 229 · cited 1×
“4 kg greater weight loss than conventional energy restriction (high-risk-of-bias RCT) [48].”
BackgroundCarter, S., Clifton, P. M., & Keogh, J. B. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.010 · Cited by 225 · cited 1×
“of-bias RCTs) [46, 47], and one for time-restricted dieting reported 1.”
BackgroundQian, F., Korat, A. A., Malik, V., & Hu, F. B. (2016) · Diabetes Care · doi:10.2337/dc16-0513 · Cited by 222 · cited 7×
“AMSTAR A Measurement Tool to Assess Systematic Reviews DiRECT Diabetes Remission Clinical Trial GRADE Grading of Recommendations, Assessment, Development and Evaluations ITT Intention to treat LCD Low-carbohydrate diet LFD Low-fat diet MUFA Monounsaturated fatty acid NRS Non-randomised study VLED Very low energy diet…”
BackgroundInfluentialMeng, Y., Bai, H., Wang, S., Li, Z., Wang, Q., & Chen, L. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.006 · Cited by 221 · cited 3×
“McArdle et al, 2019 (1) [34] McArdle et al, 2019 (2) [34] Meng et al, 2017 [33] Snorgaard et al, 2017 [31]”
BackgroundIntermittent fasting and weight loss: Systematic review.
(2020) · Europe PMC (PubMed Central) · Cited by 206
Esposito, K., Maiorino, M. I., Petrizzo, M., Bellastella, G., & Giugliano, D. (2014) · Diabetes Care · doi:10.2337/dc13-2899 · Cited by 205
Viguiliouk, E., Kendall, C. W., Kahleová, H., Rahelić, D., Salas-Salvadó, J., Choo, V. L., Mejia, S. B., Stewart, S. E., Leiter, L. A., Jenkins, D. J., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.05.032 · Cited by 201 · cited 4×
“Adherence assessed up to 1 year was poorer with very low- Critically low Critically low Critically low Critically low Critically low Critically low Critically low Critically low RCT (n) 2 (100) 2 (100) 9 (931) 18 (882) 7 (499) 7 (424) 10 (1163) 17 (1587) 5 (174) 4 (201) 7 (537) 5 (483) 2 (176) 4 (321) 4 (274) 3 (281)…”
BackgroundInfluentialvan Zuuren, E. J., Fedorowicz, Z., Kuijpers, T., & Pijl, H. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy096 · Cited by 177 · cited 2×
“Korsmo-Haugen et al, 2019 [37] van Zuuren et al, 2018 [38] Sainsbury et al, 2018 [39] Naude et al, 2014 [40] Snorgaard et al, 2017 [31] Ajala et al, 2013 [26] High-protein diet 0.30 (−1.0, 1.6) 0.10 (−0.3, 0.6) −0.14 (−1.6, 1.4) 0.58 (−0.8, 2.0) 0.91 (−2.1, 3.9) 0.20 (−1.0, 1.4) 0.4 (−1.0,…”
InfluentialWright, A. K., Kontopantelis, E., Emsley, R., Buchan, I., Sattar, N., Rutter, M. K., & Ashcroft, D. M. (2017) · Diabetes Care · doi:10.2337/dc16-1616 · Cited by 173
Role of Physical Activity for Weight Loss and Weight Maintenance
Cox, C. E. (2017) · Diabetes Spectrum · doi:10.2337/ds17-0013 · Cited by 167
Unick, J. L., Neiberg, R. H., Hogan, P. E., Cheskin, L. J., Dutton, G. R., Jeffery, R., Nelson, J. A., Pi-Sunyer, X., West, D. S., Wing, R. R., et al. (2015) · Obesity · doi:10.1002/oby.21112 · Cited by 161
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s008 · Cited by 158
Sjögren, P., Becker, W., Warensjö, E., Olsson, E., Byberg, L., Gustafsson, I., Karlström, B., & Cederholm, T. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29345 · Cited by 153
Mazidi, M., Katsiki, N., Mikhailidis, D. P., Sattar, N., & Banach, M. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz174 · Cited by 153
Chiu, S., Williams, P. T., & Krauss, R. M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170664 · Cited by 127 · cited 1×
“Replacing high-carbohydrate foods with red or processed meat (high animal protein and fat) increases sodium and long-chain saturated fat intakes, elevating LDL-cholesterol [15, 16] and potentially increasing cardiovascular disease risk [78–80].”
BackgroundA guide to prospective meta-analysis
Seidler, A. L., Hunter, K. E., Cheyne, S., Ghersi, D., Berlin, J. A., & Askie, L. (2019) · BMJ · doi:10.1136/bmj.l5342 · Cited by 125 · cited 1×
“Alternatively, the very large amount of work entailed in conducting repeated meta-analyses, and the limitations of different inclusion criteria and detailed methods, support a prospective meta-analysis approach [100, 101].”
BackgroundAl-Mrabeh, A., Hollingsworth, K. G., Shaw, J. A. M., McConnachie, A., Sattar, N., Lean, M. E. J., & Taylor, R. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30303-x · Cited by 122
Self-citationLow-carbohydrate diets for overweight and obesity: A systematic review of the systematic reviews
Churuangsuk, C., Kherouf, M., Combet, E., & Lean, M. (2018) · Obesity Reviews · doi:10.1111/obr.12744 · Cited by 118
Self-citationLeow, Z. Z. X., Guelfi, K. J., Davis, E. A., Jones, T. W., & Fournier, P. A. (2018) · Diabetic Medicine · doi:10.1111/dme.13663 · Cited by 115 · cited 1×
“Hypoglycaemia is possible if hypoglycaemic drugs are also taken [74].”
BackgroundKorsmo‐Haugen, H., Brurberg, K. G., Mann, J., & Aas, A. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13499 · Cited by 115 · cited 1×
“carbohydrate diets (<50 g of carbohydrate) than with LCDs (<130 g of carbohydrate) [34, 37, 40], possibly because most of the trials allowed increased carbohydrate intake for later weight loss maintenance.”
BackgroundPredictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT)
Thom, G., Messow, C. ‐., Leslie, W. S., Barnes, A. C., Brosnahan, N., McCombie, L., Al‐Mrabeh, A., Zhyzhneuskaya, S., Welsh, P., Sattar, N., et al. (2021) · Diabetic Medicine · doi:10.1111/dme.14395 · Cited by 113 · cited 1×
“A non-diabetic state can be restored for 2 years for 70–80% of people with type 2 diabetes by interventions that maintain over 10 kg weight loss (36/149, 24% of participants in the Diabetes Remission Clinical Trial [DiRECT]) [7], which sustains loss of ectopic fat, reversing the pathophysiology and normalising pancrea…”
BackgroundSelf-citationGardner, C. D., Kim, S., Bersamin, A., Dopler-Nelson, M., Otten, J., Oelrich, B., & Cherin, R. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29468 · Cited by 107 · cited 1×
“Diets other than nutritionally complete formula diets could incur vitamin and mineral deficiencies [75].”
BackgroundHall, L. M. L., Moran, C. N., Milne, G. R., Wilson, J., MacFarlane, N. G., Forouhi, N. G., Hariharan, N., Salt, I. P., Sattar, N., & Gill, J. M. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014197 · Cited by 106 · cited 1×
“South Asians develop type 2 diabetes at younger ages, more rapidly and with lower BMI, so may be more sensitive to weight loss, with physiological differences in insulin resistance, body composition and fat oxidation [98, 99].”
BackgroundPan, B., Wu, Y., Yang, Q., Ge, L., Gao, C., Xun, Y., Tian, J., & Ding, G. (2019) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12312 · Cited by 99 · cited 1×
“One metaanalysis used a network method to consider both direct and indirect comparisons between multiple diets (Mediterranean diets, low-carbohydrate diets [LCDs], low-fat diets [LFDs], high-carbohydrate diets and usual diets) [25].”
MethodPalladino, R., Tabak, A. G., Khunti, K., Valabhji, J., Majeed, A., Millett, C., & Vamos, E. P. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001061 · Cited by 98 · cited 1×
“However, many people in remission from type 2 diabetes remain in the prediabetes range of HbA1c, where cardiovascular disease risk begins to rise [92, 93].”
BackgroundKetoacidosis during a Low-Carbohydrate Diet
Shah, P., & Isley, W. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmc052709 · Cited by 95
Impacts of carbohydrate‐restricted diets on micronutrient intakes and status: A systematic review
Churuangsuk, C., Griffiths, D., Lean, M. E. J., & Combet, E. (2019) · Obesity Reviews · doi:10.1111/obr.12857 · Cited by 92 · cited 2×
“With ketogenic diets, heart failure and neurological problems from thiamine deficiency have been reported [76, 77], as well as reduced intakes of folate, iron and magnesium [12].”
BackgroundSelf-citationFesti, D., Colecchia, A., Orsini, M., Sangermano, A., Sottili, S., Simoni, P., Mazzella, G., Villanova, N., Bazzoli, F., Lapenna, D., et al. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800634 · Cited by 90 · cited 1×
“Meanwhile, extreme fat avoidance provokes cholelithiasis [88].”
Dambha‐Miller, H., Day, A. J., Strelitz, J., Irving, G., & Griffin, S. J. (2020) · Diabetic Medicine · doi:10.1111/dme.14122 · Cited by 86 · cited 3×
“Loss of >10% of baseline body weight in the first year after diagnosis was associated with 70% higher chance of remission at 5 years [96].”
BackgroundSelf-citationLara-Castro, C., Newcomer, B. R., Rowell, J., Wallace, P., Shaughnessy, S. M., Munoz, A. J., Shiflett, A. M., Rigsby, D. Y., Lawrence, J. C., Bohning, D. E., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2007.05.008 · Cited by 82 · cited 2×
“Ectopic fat accumulation in liver, pancreas and muscle impairs organ functions, resulting in hyperglycaemia, commonly associated with hypertension and dyslipidaemia [2, 3].”
BackgroundBhopal, R. S. (2013) · Diabetic Medicine · doi:10.1111/dme.12016 · Cited by 77 · cited 1×
“South Asians develop type 2 diabetes at younger ages, more rapidly and with lower BMI, so may be more sensitive to weight loss, with physiological differences in insulin resistance, body composition and fat oxidation [98, 99].”
BackgroundUnwin, D., Khalid, A. A., Unwin, J., Crocombe, D., Delon, C., Martyn, K., Golubic, R., & Ray, S. (2020) · BMJ Nutrition, Prevention & Health · doi:10.1136/bmjnph-2020-000072 · Cited by 73 · cited 2×
“5% of the practice achieved remission [95].”
BackgroundNoronha, J. C., Nishi, S. K., Braunstein, C. R., Khan, T. A., Blanco Mejia, S., Kendall, C. W. C., Kahleová, H., Rahelić, D., Salas-Salvadó, J., Leiter, L. A., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2270 · Cited by 65 · cited 4×
“Only seven meta-analyses (LCDs, n = 5 [37–40, 41]; liquid meal replacement, n = 1 [42]; very low energy diet (VLED), n = 1 [43]) were assessed as high quality.”
BackgroundInfluentialRehackova, L., Arnott, B., Araujo‐Soares, V., Adamson, A. A., Taylor, R., & Sniehotta, F. F. (2016) · Diabetic Medicine · doi:10.1111/dme.13005 · Cited by 60 · cited 4×
“High adherence to VLEDs (up to 6 months), judged from rapid early weight loss and dietary assessment, led to better long-term results [43].”
BackgroundInfluentialMcArdle, P. D., Greenfield, S. M., Rilstone, S. K., Narendran, P., Haque, M. S., & Gill, P. S. (2019) · Diabetic Medicine · doi:10.1111/dme.13862 · Cited by 60 · cited 8×
“…al, 2019 [35] Vegetarian diet Goldenberg et al, 2021 [41] Korsmo-Haugen et al, 2019 [37] van Zuuren et al, 2018 [38] Sainsbury et al, 2018 [39] Naude et al, 2014 [40] McArdle et al, 2019 (1) [34] McArdle et al, 2019 (2) [34] Meng et al, 2017 [33] Snorgaard et al, 2017 [31] Fan et al, 2016…”
BackgroundResultInfluentialThe Effects of Different Quantities and Qualities of Protein Intake in People with Diabetes Mellitus
Pfeiffer, A. F. H., Pedersen, E., Schwab, U., Risérus, U., Aas, A.-M., Uusitupa, M., Thanopoulou, A., Kendall, C., Sievenpiper, J. L., Kahleová, H., et al. (2020) · Nutrients · doi:10.3390/nu12020365 · Cited by 60 · cited 4×
“…(741) 6 (771) 10 (997) 9 (844) 6 (532) 24 (1488) 3 (357) 6 (835) 4 (1397) 16 (1081) 5 (265) 16 (1059) 2 (137) Favour intervention Favour control Pfeiffer et al, 2020 [28] Zhao et al, 2018 [30] Ajala et al, 2013 [26] High High High High High High High Low Low Critically low Low Low Low 3…”
BackgroundInfluentialGutierrez‐Mariscal, F. M., Cardelo, M. P., de la Cruz, S., Alcala‐Diaz, J. F., Roncero‐Ramos, I., Guler, I., Vals‐Delgado, C., López‐Moreno, A., Luque, R. M., Delgado‐Lista, J., et al. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201901290 · Cited by 60
Xin, Y., Davies, A., Briggs, A., McCombie, L., Messow, C. M., Grieve, E., Leslie, W. S., Taylor, R., & Lean, M. E. J. (2020) · Diabetologia · doi:10.1007/s00125-020-05224-2 · Cited by 52 · cited 1×
“For diabetes remission, a total diet replacement programme was estimated to be both more cost-effective and cost-saving than standard care in the DiRECT trial, reflecting reduced need for medications and fewer diabetes complications [63].”
BackgroundSelf-citationMottalib, A., Sakr, M., Shehabeldin, M., & Hamdy, O. (2015) · Journal of Diabetes Research · doi:10.1155/2015/468704 · Cited by 44
Umphonsathien, M., Prutanopajai, P., Aiam‐O‐Ran, J., Thararoop, T., Karin, A., Kanjanapha, C., Jiamjarasrangsi, W., & Khovidhunkit, W. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.956 · Cited by 44
Vitale, R., & Kim, Y. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0048 · Cited by 43 · cited 2×
“Currently popular intermittent fasting was only captured in systematic reviews without metaanalysis (high-risk-of-bias RCTs) [44, 45].”
BackgroundSarathi, V., Kolly, A., Chaithanya, H., & Dwarakanath, C. (2017) · Journal of Natural Science, Biology and Medicine · doi:10.4103/0976-9668.198343 · Cited by 39
High protein diet is of benefit for patients with type 2 diabetes: An updated meta-analysis
Zhao, W.-T., Luo, Y., Zhang, Y., Zhou, Y., & Zhao, T.-T. (2018) · Medicine · doi:10.1097/md.0000000000013149 · Cited by 38
Bynoe, K., Unwin, N. C., Taylor, C. G., Murphy, M. M., Bartholomew, L., Greenidge, A., Abed, M. T., Jeyaseelan, S. M., Cobelli, C., Man, C. D., et al. (2019) · Diabetic Medicine · doi:10.1111/dme.14096 · Cited by 38
Kent, S., Aveyard, P., Astbury, N., Mihaylova, B., & Jebb, S. A. (2019) · Obesity · doi:10.1002/oby.22407 · Cited by 35 · cited 1×
“In the Doctor Referral of Overweight People to Low Energy total diet replacement Treatment (DROPLET) trial among people without diabetes, in routine practice, a total diet replacement programme (formula diets) with behavioural support proved more costeffective than nurse-led dietary advice for long-term prevention of…”
BackgroundChuruangsuk, C., Lean, M. E. J., & Combet, E. (2020) · Proceedings of The Nutrition Society · doi:10.1017/s0029665120000105 · Cited by 35
Self-citationCost‐Effectiveness of a Low‐Carbohydrate Diet and a Standard Diet in Severe Obesity
Tsai, A. G., Glick, H. A., Shera, D., Stern, L., & Samaha, F. F. (2005) · Obesity Research · doi:10.1038/oby.2005.223 · Cited by 33 · cited 1×
“The evidence on relative cost-effectiveness of weight-loss diet programmes is limited from head-to-head diet comparison trials, but one RCT showed that LCD was not more cost-effective than the standard weight-loss diet [61].”
BackgroundKleinherenbrink, W., Osei, E., den Hertog, H. M., & Zandbergen, A. A. M. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.07.001 · Cited by 31
Churuangsuk, C., Lean, M. E. J., & Combet, E. (2020) · Scientific Reports · doi:10.1038/s41598-020-70905-2 · Cited by 28
Self-citationLOW‐CARBOHYDRATE DIET OPTIC NEUROPATHY
Hoyt, C. S., & Billson, F. A. (1977) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1977.tb130506.x · Cited by 26
Davé, R., Davis, R., & Davies, J. S. (2019) · Obesity Medicine · doi:10.1016/j.obmed.2019.01.005 · Cited by 24
Ketogenic Diet as a Trigger for Diabetic Ketoacidosis in a Misdiagnosis of Diabetes: A Case Report
White-Cotsmire, A. J., & Healy, A. M. (2020) · Clinical Diabetes · doi:10.2337/cd20-0001 · Cited by 22
Abbie, M., Douglas, H. M., & Ross, K. E. (1978) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1978.tb112466.x · Cited by 20
Obesity in older adults: Effect of degree of weight loss on cardiovascular markers and medications
Haywood, C. J., Prendergast, L. A., Lim, R., Lappas, M., Lim, W. K., & Proietto, J. (2019) · Clinical Obesity · doi:10.1111/cob.12316 · Cited by 19 · cited 1×
“Blood pressure falls with weight loss, and postural hypotension, common in older people and those with diabetes, is aggravated during rapid weight loss if diuretic or antihypertensive drugs are taken concurrently [73].”
BackgroundSeeing double: the low carb diet
McKenna, L. A., Drummond, R. S., Drummond, S., Talwar, D., & Lean, M. E. (2013) · BMJ · doi:10.1136/bmj.f2563 · Cited by 18
Self-citationElidottir, A. S., Halldorsson, T. I., Gunnarsdottir, I., & Ramel, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0156655 · Cited by 18 · cited 1×
“Replacing high-carbohydrate foods with red or processed meat (high animal protein and fat) increases sodium and long-chain saturated fat intakes, elevating LDL-cholesterol [15, 16] and potentially increasing cardiovascular disease risk [78–80].”
BackgroundVery low carbohydrate diet and SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis
Tougaard, N. H., Faber, J., & Eldrup, E. (2019) · BMJ Case Reports · doi:10.1136/bcr-2018-227516 · Cited by 16
Ketogenic Diet‐Induced Diabetic Ketoacidosis in a Young Adult with Unrecognized Type 1 Diabetes
Charoensri, S., Sothornwit, J., Trirattanapikul, A., & Pongchaiyakul, C. (2021) · Case Reports in Endocrinology · doi:10.1155/2021/6620832 · Cited by 14
Dambha-Miller, H., Day, A., Kinmonth, A. L., & Griffin, S. J. (2021) · Family Practice · doi:10.1093/fampra/cmaa086 · Cited by 12 · cited 2×
“There is therefore consistent evidence that remission should be attempted as early as possible from diabetes diagnosis [70, 96].”
BackgroundSelf-citationMollentze, W. F., Joubert, G., Prins, A., van der Linde, S., Marx, G. M., & Tsie, K. G. (2019) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-019-00734-1 · Cited by 11 · cited 1×
“Among these, three provided diabetes education or advice (Table 2) [49, 50, 52].”
BackgroundMarzban, S., Arbee, M., Vorajee, N., & Richards, G. A. (2020) · Oxford Medical Case Reports · doi:10.1093/omcr/omz026 · Cited by 10
Shaikh, S., Mohamed, M. M., Mujeeb, A., Shaikh, F., & Harris, B. (2020) · Cureus · doi:10.7759/cureus.10199 · Cited by 10
Thomas, N. D., & Shamanna, S. B. (2019) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0706-2 · Cited by 4 · cited 1×
“2 kg (N = 9, one single-arm intervention; GRADE very low certainty of evidence; critical risk of bias) [60].”
Background
Research works printed but not linked: 1
- Fan YF, Di HJ, Chen GF, Mao XD, Liu C (2016) Effects of low carbohydrate diets in individuals with type 2 diabetes: systematic review and meta-analysis. Int J Clin Exp Med 9(6):11166–11174
Cited by
Ahmad, E., Lim, S., Lamptey, R., Webb, D. R., & Davies, M. J. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01655-5 · Cited by 1,120
Evidence-based European recommendations for the dietary management of diabetes
The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), Aas, A.-M., Axelsen, M., Churuangsuk, C., Hermansen, K., Kendall, C. W. C., Kahleova, H., Khan, T., Lean, M. E. J., Mann, J. I., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05894-8 · Cited by 262
“These recommendations for body weight and weight loss are supported by published systematic reviews undertaken to inform the DNSG [27, 28] and by broader evidence relevant to weight management for people with diabetes.”
InfluentialSelf-citationPapakonstantinou, E., Oikonomou, C., Nychas, G., & Dimitriadis, G. D. (2022) · Nutrients · doi:10.3390/nu14040823 · Cited by 199
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Kelly, T., Irvine, K., Peters, C., Zhyzhneuskaya, S., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00385-6 · Cited by 186
Self-citationUltraprocessed Foods and Obesity Risk: A Critical Review of Reported Mechanisms
Valicente, V. M., Peng, C.-H., Pacheco, K. N., Lin, L., Kielb, E. I., Dawoodani, E., Abdollahi, A., & Mattes, R. D. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.04.006 · Cited by 144
Metadata
- Authors
- Churuangsuk, C., Hall, J., Reynolds, A., Griffin, S. J., Combet, E., & Lean, M. E. J.
- Affiliations
- Prince of Songkla University (TH)
- University of Glasgow (GB)
- University of Otago (NZ)
- University of Cambridge (GB)
- Corresponding author
- Lean, Michael E. J.
- ORCID
- Venue
- Diabetologia
- Published
- 2021-11-17
- Volume
- 65
- Issue
- 1
- Pages
- 14-36
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC8660762
- OpenAlex
- W3191307854
- Semantic Scholar
- 54e916ea7ac77f19855fef08c2849bca101e9ad7
- Cited by
- 204
- References
- 105
- Citations by year
- 2026: 27 · 2025: 55 · 2024: 47 · 2023: 44 · 2022: 29 · 2021: 1
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- National Institute for Health and Care Research
- University of Glasgow
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- type 2 diabetes, weight loss diet, diabetes remission, weight management, very low calorie diet, hypocaloric diet, low-carbohydrate diet, low-fat diet, Mediterranean diet
- MeSH terms
- Systematic Reviews as Topic, Adult, Clinical Trials as Topic, Diabetes Mellitus, Type 2, Humans, Meta-Analysis as Topic, Weight Loss, Diet, Fat-Restricted, Diet, Carbohydrate-Restricted
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.